Braun Stacey Associates’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$37.1M Sell
47,653
-2,670
-5% -$2.08M 1.34% 14
2025
Q1
$41.6M Sell
50,323
-1,732
-3% -$1.43M 1.7% 12
2024
Q4
$40.2M Sell
52,055
-3,559
-6% -$2.75M 1.5% 13
2024
Q3
$49.3M Sell
55,614
-10,035
-15% -$8.89M 1.87% 7
2024
Q2
$59.4M Sell
65,649
-655
-1% -$593K 2.3% 7
2024
Q1
$51.6M Sell
66,304
-300
-0.5% -$233K 2.04% 6
2023
Q4
$38.8M Sell
66,604
-5,265
-7% -$3.07M 1.74% 7
2023
Q3
$38.6M Sell
71,869
-4,311
-6% -$2.32M 1.88% 7
2023
Q2
$35.7M Sell
76,180
-77,814
-51% -$36.5M 1.66% 6
2023
Q1
$52.9M Buy
153,994
+77,415
+101% +$26.6M 1.38% 10
2022
Q4
$28M Sell
76,579
-1,726
-2% -$631K 1.6% 5
2022
Q3
$25.3M Sell
78,305
-1,090
-1% -$352K 1.54% 7
2022
Q2
$25.7M Buy
79,395
+505
+0.6% +$164K 1.47% 8
2022
Q1
$22.6M Buy
78,890
+1,815
+2% +$520K 0.94% 38
2021
Q4
$21.3M Buy
77,075
+3,304
+4% +$913K 0.78% 57
2021
Q3
$17M Buy
73,771
+3,515
+5% +$812K 0.68% 76
2021
Q2
$16.1M Buy
70,256
+2,632
+4% +$604K 0.63% 81
2021
Q1
$12.6M Buy
+67,624
New +$12.6M 0.53% 94
2020
Q4
Sell
-1,675
Closed -$248K 137
2020
Q3
$248K Hold
1,675
0.01% 120
2020
Q2
$275K Buy
+1,675
New +$275K 0.02% 117
2016
Q3
Sell
-3,700
Closed -$291K 155
2016
Q2
$291K Sell
3,700
-2,900
-44% -$228K 0.02% 140
2016
Q1
$475K Hold
6,600
0.03% 128
2015
Q4
$556K Hold
6,600
0.03% 115
2015
Q3
$552K Sell
6,600
-3,700
-36% -$309K 0.04% 116
2015
Q2
$860K Buy
10,300
+3,700
+56% +$309K 0.04% 201
2015
Q1
$479K Buy
6,600
+1,000
+18% +$72.6K 0.03% 119
2014
Q4
$386K Hold
5,600
0.02% 123
2014
Q3
$363K Buy
5,600
+300
+6% +$19.4K 0.02% 126
2014
Q2
$330K Buy
5,300
+1,000
+23% +$62.3K 0.02% 132
2014
Q1
$253K Hold
4,300
0.01% 137
2013
Q4
$219K Hold
4,300
0.01% 144
2013
Q3
$216K Hold
4,300
0.01% 140
2013
Q2
$211K Buy
+4,300
New +$211K 0.01% 154